Medindia

X

Sentillion Ranked #1 Vendor in KLAS' Single Sign-On & Context Management Report

Thursday, March 20, 2008 General News J E 4
Advertisement
ANDOVER, Mass., March 19 Sentillion, the company thatcreated healthcare Single Sign-On (SSO), announced today that it ranked #1 inthe most comprehensive healthcare industry report comparing SSO and contextmanagement vendors performance. The Single Sign-On/Context Management Report(February, 2008) published by the healthcare industry's leading independentresearch firm, KLAS, utilized surveys and interviews with 146 healthcareprovider organizations to determine the performance of several SSO and contextmanagement vendors, including: CA, Carefx(1), Encentuate, Healthcast,Imprivata, Novell and Passlogix. The KLAS report cited Sentillion as the onlyvendor able to offer both SSO and context management, without requiring apartner.

"When we speak to Sentillion's customers they identify Sentillion(R)support as their strongest asset and convey the huge successes they haveachieved within their physician community," said Paul Pitcher, KLAS researchdirector and author of the report.

Based on its customers' ratings, Sentillion received the best overallscore of 87.50 making it the highest performing vendor. In addition, 58% ofsurveyed providers ranked Sentillion as their best IT vendor, which was insharp contrast to all the vendors in the report who measured 29% or below.Sentillion also led in categories pertaining to:

For the past two years, Sentillion has maintained a consistent score wellabove the KLAS average and in 2007 the company was named the #1 SSO vendor inKLAS Top 20: 2007 Year-End Report.

"The SSO market is crowded and on the surface, each vendor looks andsounds alike. We applaud KLAS for taking the initiative by going out toprovider organizations, talking to them about their experiences and providingan honest and accurate assessment of the state of the SSO marketplace," saidPaul Roscoe, president, Sentillion. "We view customer satisfaction as thenumber one indicator of a vendor's performance, and we are very pleased thatour own customers continue to recognize us for our technology, services andsupport and our proven ability to get them live quickly."

To obtain a copy of the KLAS Single Sign-On/Context Management report,please visit: http://www.KLASresearch.com

(1) measured for context management performance only.

About KLAS

Founded in 1996, KLAS is a research and consulting firm specializing inmonitoring and reporting the performance of healthcare information technology(HIT), professional services, and medical equipment vendors and products. KLASstrives to improve HIT delivery by independently measuring vendor performancefor the benefit of consultants, investors, vendors, and healthcare providerpartners. KLAS, in concert with thousands of healthcare executives andprofessionals, has created a dynamic database of HIT evaluations and opinionsof healthcare executives, managers, and clinicians from over 4,500 hospitalsand 3,000 clinics are represented in the reports, 300+ software vendors, 500+software products and 35 service firms. The Top 20 Report reflects the summaryof HIT product performance data collection over a 13-month period. For furtherinformation, contact KLAS at 801-226-5120 or on the Web athttp://www.healthcomputing.com.

About Sentillion, Inc.

Since 1998, Sentillion has been revolutionizing healthcare IT with awardwinning, industry recognized identity and access management technology.Sentillion has successfully combined patented technology with a deepunderstanding of the healthcare industry to deliver the most comprehensive setof solutions for single sign-on, user provisioning, clinical workstations andvirtualized remote access. Recently recognized as the number one single sign-on (SSO) vendor in the KLAS Top 20: 2007 Year-End Report, Sentillion is theonly identity and access management company whose solutions are used daily byover 350,000 caregivers in leading healthcare
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
White Paper Advises Pharma Manufacturers on How to...
S
MacroChem Appoints David P. Luci as New CFO